ASTELLAS TERMINATES LICENSING AGREEMENT WITH SERVIER

Astellas Pharma Inc. (4503.TO) said Tuesday it has terminated its licensing agreement on an osteoporosis drug with Laboratoires Servier SA (LSV.YY), a privately owned French drugmaker.
Therapeutics Daily